TB group licenses drugs from Novartis

08/20/2014 | Yahoo

The Global Alliance for TB Drug Development on Wednesday signed a licensing agreement with Swiss drugmaker Novartis for compounds to fight tuberculosis, including indolcarboxamides, a novel drug class that targets strains that are resistant to other treatments. Under the agreement, the Global Alliance will take on research and development of the compounds.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC